Reaction

Osteoporosis Postmenopausal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 139 reports · 3 co-occurring drugs

As of the last recalculation, Osteoporosis Postmenopausal appears in 139 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is DOXEPIN (PRR 229.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Doxepin14229.9230.2
Doxepin Hydrochloride17229.5229.9
Ranitidine Hydrochloride1960.560.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.